This cohort study evaluates the risk of suicide attempt and suicide death among spouses of patients with a cancer diagnosis in Denmark.
This prospective-retrospective translational study of patients enrolled in SOFT assesses the predictive and prognostic performance of the Breast Cancer Index for ovarian function suppression benefit in premenopausal women with hormone receptor–positive breast cancer.
This nonrandomized controlled trial investigates central nervous system (CNS) activity with lazertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.
This randomized clinical trial compares the outcomes of hypofractionation vs conventional fractionation postmastectomy radiation therapy regimens in patients undergoing implant-based breast reconstruction.
This review discusses advances in evidence-based treatment of acute myeloid leukemia with molecularly targeted drug therapy.
This essay describes a medical student’s experience caring for her sister with breast cancer.
This secondary analysis of the Cancer and Leukemia Group B 140503 randomized clinical trial examines survival and recurrence rates in patients with small peripheral pT2 non–small cell lung cancer that was treated by either lobar or sublobar resection.
This cohort study examines the use of regular aspirin use as a preventive intervention in individuals with varying risk factors for colorectal cancer.
This cohort study examines graded kidney response criteria and their association with kidney and overall survival for patients with kidney light chain amyloidosis.
This cohort study describes lung cancer incidence, diagnosis, and outcome in individuals with Li-Fraumeni syndrome.
This Viewpoint discusses the clinical vs economic success of magnetic resonance imaging combined with linear accelerator technology and its impact on patients.
This Viewpoint discusses the value of magnetic resonance imaging with linear accelerator (MRI-linac) technology, given the unmet needs in its development.